Migraine is a common neurological disease characterized by recurrent attacks of severe head pain. Often unilateral, the headaches can last from four hours to three days. Pain is often associated with other symptoms, such as nausea, vomiting, increased sensitivity to light, increased sensitivity to sound, sweating, and diarrhea. An increasing prevalence of migraine has been reported in women than men. However, it often remains undiagnosed and untreated. Despite improvements in the industry, migraine is still found to remain undiagnosed in at least 50% of patients, and less than 50% of migraine patients consult a physician. The majority of the drugs currently available are approved for the acute form of the condition, led by generic triptans as the first-line treatment. NSAIDs are the commonly used drugs for patients with migraine frequently used NSAIDs for migraine and is effective in treating acute migraine headache. Triptans also effectively relieve the pain associated with migraines.

1. INTRODUCTION  

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY 

4. MARKET DYNAMICS 

5. MARKET SEGMENTATION 

6. COMPANY PROFILES AND COMPETITIVE LANDSCAPE  

7. MARKET OPPORTUNITIES AND FUTURE TRENDS